Antifungal Agents
Itraconazole
Terbinafine
Tinea

Tinea Corporis

Tinea corporis, more commonly known as ringworm, is a superficial dermatophyte skin infection caused by fungi belonging to the genera Trichophyton, Epidermophyton, and Microsporum. This condition typically affects the body’s glabrous (nonhairy) areas and presents as annular, scaly plaques with central clearing and an active, erythematous, sometimes raised border. The infection is often pruritic and may become confluent or widespread in immunocompromised individuals. Diagnosis is typically clinical but may be confirmed through potassium hydroxide microscopy of skin scrapings, which reveals hyaline and septate hyphae. Culture or polymerase chain reaction testing may be used to identify the pathogenic species in refractory cases. Treatment involves topical antifungal agents, such as azoles and allylamines, for localized cases, whereas systemic antifungal therapy, such as oral terbinafine or itraconazole, is indicated for extensive or recalcitrant infections. Effective treatment also requires addressing predisposing factors, such as excessive perspiration, close contact with infected individuals, and the use of contaminated items. This activity for healthcare professionals is designed to enhance the learner’s competence when evaluating and managing tinea corporis. Participants improve their understanding of the condition’s epidemiology, risk factors, genetics, pathophysiology, clinical presentation, and management. Improved knowledge and skills empower clinicians to collaborate effectively within an interprofessional team, ultimately improving patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.